middle.news
How Is ReNerve Driving 38% Sales Growth with New EmpliQ Launch?
8:54am on Thursday 23rd of October, 2025 AEDT
•
Healthcare
Read Story
How Is ReNerve Driving 38% Sales Growth with New EmpliQ Launch?
8:54am on Thursday 23rd of October, 2025 AEDT
Key Points
38% quarterly sales increase to A$66,000
Launch and first sales of EmpliQ dermal and amniotic tissue products
Progress on NervAlign® Nerve Conduit production and upcoming market release
Cash reserves of A$3.27 million supporting ongoing R&D and expansion
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Renerve (ASX:RNV)
OPEN ARTICLE